Pharma M&A deal value fell by more than 92% year-on-year
According to data compiled by ComprarAcciones , M&A deal activity in the pharma sector rose by 17% during the first half of 2020. To many, this would appear to be …
How COVID-19 Has Coronated Digital the King of Healthcare Marketing
How COVID-19 Has Coronated Digital the King of Healthcare Marketing In many ways, the coronavirus pandemic has been different for each of us, but we’ve also shared many of the …
US election: where do the candidates stand on non-Covid healthcare issues?
Even beyond Covid-19 , healthcare is a major battleground in the US Presidential election that will be decided on 3 November. The two candidates – Democrat Joe Biden and Republican …
Supply chains will become more local in the pharmaceutical industry, says healthcare CEO
Drug supply chains may become less global as a result of the pandemic, according to the chief executive of a pharmaceutical manufacturer. Martin Meeson, CEO of Fujifilm Diosynth Biotechnologies, told …
We won’t get coronavirus vaccine results in October
Hollis Johnson/Business Insider Hello, Today in healthcare news: The door has closed on getting vaccine data in October, and Eli Lilly ends its antibody trial in hospitalized COVID-19 patients — …
Zebra Technologies Empowers Interdisciplinary Care with Innovative Healthcare Offerings
New purpose-built scanner and mobile computers help restore caregivers’ time and purpose Zebra Technologies Corporation (NASDAQ: ZBRA), an innovator at the front line of business with solutions and partners that …
Q&A: Breaking new ground in pharma packaging with Honeywell
These are interesting times for pharma packaging company Honeywell. Known for Aclar – a moisture barrier film for oral solid dose packaging – the company recently broke new ground with …
Ho Wah secures licence to distribute pharmaceutical products in Indonesia
Ho Wah Genting Bhd, through Indonesian subsidiary PT Ho Wah Genting, is ready to tap into the fastest growing pharmaceutical market in Asean while maintaining its existing line of business …
Who will receive COVID-19 vaccines first?
EPR ’s Hannah Balfour discusses some of the proposed COVID-19 vaccine distribution plans and how medicinal nationalism and supply deals could prevent “fair and equitable access” to COVID-19 vaccines. There …
Novartis vets get $35M to pluck one of the pharma giant’s abandoned drugs off the shelf and put it back into a clinical trial
Back in 2006, Novartis execs scooped up rights to Kyorin’s immunosuppressant drug program for KRP-203, an S1P drug that the pharma giant initially thought had some real potential. But Mayzent …